• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

5 months ago
Pharma

Cal­tech spin­out de­buts with AI-dri­ven 'mir­ror pep­tide' plat­form

5 months ago
R&D

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

5 months ago
Deals
R&D

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

5 months ago
People
Pharma

Ky­owa Kirin ac­quires ex-US rights to Ku­ra’s leukemia treat­ment for $330M up­front

5 months ago
Deals

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

5 months ago
R&D
Pharma

Ven­rock adds $500M to health­care in­vest­ing strat­e­gy af­ter out­lin­ing 10th fund in Jan­u­ary

5 months ago
Financing
Startups

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

5 months ago
Pharma
FDA+

When gen­er­a­tive AI meets the FDA: First dig­i­tal health ad­comm kicks off dis­cus­sion

5 months ago
AI
FDA+

No­vo and Viking present new MASH da­ta, but an­a­lysts re­main con­fi­dent in Madri­gal's Rezd­if­fra

5 months ago
R&D

23andMe inks new re­search part­ner­ship as it winds down in­ter­nal drug de­vel­op­ment ef­forts

5 months ago
Deals
Health Tech

Up­dat­ed: Sage re­ports Phase 2 fail­ure in Hunt­ing­ton's dis­ease, ends drug's de­vel­op­ment

5 months ago
R&D

Pfiz­er taps on­col­o­gy head Boshoff as Dol­sten's chief sci­en­tif­ic of­fi­cer suc­ces­sor

5 months ago
People
Pharma

Car­olyn Bertozzi’s lat­est biotech de­buts with $30M seed round and a sug­ary spin on im­munother­a­py

5 months ago
Financing
Startups

Ex­clu­sive: For­mer Pfiz­er com­mer­cial chief An­gela Hwang to join Flag­ship

5 months ago
People
Startups

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

5 months ago
Startups
Deals

GSK plots reg­u­la­to­ry fil­ings for PBC itch af­ter pos­i­tive Phase 3 read­out

5 months ago
Pharma
FDA+

NICE has 'done all we can' to ne­go­ti­ate for En­her­tu cov­er­age, reaf­firms de­ci­sion not to rec­om­mend

5 months ago
Pharma

FDA re­jects Astel­las’ ef­fort to sup­port longer use of eye drug Iz­er­vay 

5 months ago
Pharma
FDA+

Ahead of ad­comm, FDA rais­es safe­ty ques­tions for As­traZeneca’s re­ver­sal agent for life-threat­en­ing bleeds

5 months ago
Pharma
FDA+

Chi­nese drug­mak­er re­ceives FDA warn­ing let­ter af­ter man­age­ment hin­dered in­spec­tion

5 months ago
FDA+
Manufacturing

BeiGene set­tles fi­nal suit over fu­ture Brukin­sa gener­ics

5 months ago
Pharma
Law

Lil­ly’s oral car­dio drug that blocks lipids pass­es mid-stage test

5 months ago
R&D

J&J, Pro­tag­o­nist re­veal two Phase 3 wins for oral IL-23 drug that's ex­pect­ed to be a block­buster

5 months ago
R&D
First page Previous page 62636465666768 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times
Endpoints News

Log in to your account

email

password

Endpoints News

request login link

Enter the email associated to with your Endpoints account, and we'll send you a one-time login link (no password needed). The link expires after 24 hours.

email

Endpoints News

reset password

Enter the email associated to with your Endpoints account, and we'll send you a link to reset your password. The link expires after 24 hours and can only be used once.

email

Endpoints News

Sign up for free to read a limited number of articles each month.

About You

Newsletter Interests

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Want unlimited access? Sign up for a premium subscription plan.